局部晚期口腔鳞癌pN0患者可安全省略术后颈部放疗
该回顾性单中心研究纳入77例pT3-T4pN0口腔鳞癌患者,均接受原发手术、彻底颈淋巴结清扫(≥18枚)及仅限瘤床的术后放疗。中位随访51个月,仅3例淋巴结复发且均伴局部复发,无孤立性颈部失败,区域控制率96%,5年OS和DFS分别为77.6%和79.2%。结论认为在高选择pN0患者中省略术后颈部放疗不损害肿瘤学结局。
要点
- pT3-T4pN0口腔鳞癌经彻底颈清扫后省略颈部放疗,区域控制率96%。
- 仅3例淋巴结复发均伴局部肿瘤复发,无孤立性颈部失败。
- 5年OS为77.6%、DFS为79.2%,支持选择性降阶梯治疗。
核心结论
- 在经高质量颈淋巴结清扫的pT3-T4pN0口腔鳞癌患者中,省略术后颈部放疗不损害肿瘤学结局。
研究设计与样本
- 回顾性单中心研究,纳入77例接受原发手术、彻底颈淋巴结清扫(≥18枚)及仅限瘤床术后放疗的pT3-T4pN0口腔鳞癌患者。
主要发现
- 中位随访51个月,仅3例发生淋巴结复发,且均与局部肿瘤复发相关,无孤立性颈部失败。
- 区域控制率为96%,5年总生存率为77.6%,5年无病生存率为79.2%。
关键数值与推荐
- 彻底颈淋巴结清扫定义为清扫≥18枚淋巴结。
- 术后放疗仅限瘤床,省略颈部照射。
临床怎么用
- 对接受彻底颈清扫的pT3-T4pN0口腔鳞癌患者,可考虑省略术后颈部放疗以减少照射体积和潜在治疗相关并发症。
局限性
- 回顾性单中心设计,样本量有限(77例),结论需前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postoperative radiotherapy is the standard treatment for locally advanced oral squamous cell carcinoma (OSCC); however, the indication for neck irradiation (NI) in pN0 patients remains debatable. We evaluated whether the omission of NI compromises outcomes in pT3-T4 pN0 patients treated with adequate neck dissection (ND). METHODS: This retrospective single-institution study included patients with pT3-T4pN0 OSCC who underwent primary surgery, exhaustive ND (≥ 18 lymph nodes), and postoperative radiotherapy limited to the tumor bed. Overall survival (OS), disease-free survival (DFS), and regional control were also analyzed. RESULTS: Seventy-seven patients were included in the study. After a median follow-up of 51 months, only three nodal recurrences occurred, all associated with local tumor relapse. No isolated neck failures were observed. The regional control rate was 96% and the 5-year OS and DFS rates were 77.6% and 79.2%, respectively. CONCLUSION: In selected pT3-T4 pN0 OSCC patients undergoing high-quality ND, omission of postoperative NI does not compromise oncologic outcomes. This strategy allows for a meaningful reduction in irradiation volumes and potentially treatment-related morbidity, supporting de-escalation of treatment.
引用
- Mirallié M, Modesto A, Pajiep M, et al. Safe Omission of Postoperative Neck Irradiation in Selected pN0 Patients With Locally Advanced Oral Cavity Squamous Cell Carcinoma. Head Neck. 2026. PMID: 42298898. doi:10.1002/hed.70325
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。